AquaBounty Technologies, founded in the United States, is a biotechnology company dedicated to enhancing aquaculture productivity. The company's core mission is to address the global demand for high-quality seafood through innovative, sustainable solutions. AquaBounty specializes in genetically engineered Atlantic salmon, raised in land-based farms designed to be environmentally friendly and efficient. Their market focus includes both the United States and international regions seeking sustainable seafood options.
Notable figures associated with AquaBounty include key investors from the biotechnology and aquaculture sectors. The company has achieved significant milestones, such as receiving FDA approval for its genetically engineered salmon, making it the first of its kind to be approved for human consumption in the U.S. AquaBounty's impact is evident in its contribution to sustainable aquaculture practices and its potential to revolutionize seafood production globally.
